NYSE:LLY - Eli Lilly And Co News Headlines

Sign in or create an account to add this stock to your watchlist.
$106.33 +0.26 (+0.25 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$106.33
Today's Range$105.35 - $106.87
52-Week Range$73.69 - $107.84
Volume5.33 million shs
Average Volume3.25 million shs
Market Capitalization$113.92 billion
P/E Ratio24.84
Dividend Yield2.12%
Beta0.28

Headlines

Eli Lilly And Co (NYSE LLY) News Headlines

Source:
DateHeadline
Market Rallies Despite Trade Worries: 5 Blue-Chip PicksMarket Rallies Despite Trade Worries: 5 Blue-Chip Picks
finance.yahoo.com - September 21 at 4:47 PM
[$$] Lilly Approval to Spur Migraine-Prevention Market in Europe[$$] Lilly Approval to Spur Migraine-Prevention Market in Europe
finance.yahoo.com - September 21 at 4:47 PM
Elanco’s $1.7 billion IPO looks too pricey, and here’s whyElanco’s $1.7 billion IPO looks too pricey, and here’s why
finance.yahoo.com - September 20 at 8:39 AM
Outside the Box: Elanco’s $1.6 billion IPO looks too pricey, and here’s whyOutside the Box: Elanco’s $1.6 billion IPO looks too pricey, and here’s why
www.marketwatch.com - September 20 at 2:33 AM
Eli Lilly And Co (LLY) SVP Alfonso G. Zulueta Sells 6,000 SharesEli Lilly And Co (LLY) SVP Alfonso G. Zulueta Sells 6,000 Shares
www.americanbankingnews.com - September 19 at 7:30 PM
Elanco Announces Pricing of Initial Public OfferingElanco Announces Pricing of Initial Public Offering
finance.yahoo.com - September 19 at 5:30 PM
Elanco’s $1.6 billion IPO looks too pricey, and here’s whyElanco’s $1.6 billion IPO looks too pricey, and here’s why
finance.yahoo.com - September 19 at 5:30 PM
J&J Files NDA for Erdafitinib in Urothelial Cancer IndicationJ&J Files NDA for Erdafitinib in Urothelial Cancer Indication
finance.yahoo.com - September 19 at 5:30 PM
Pharma Stocks in Review: A Valuation ComparisonPharma Stocks in Review: A Valuation Comparison
finance.yahoo.com - September 19 at 8:41 AM
Insider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 9,009 Shares of StockInsider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 9,009 Shares of Stock
www.americanbankingnews.com - September 18 at 10:26 PM
Eli Lilly And Co (LLY) Major Shareholder Eli & Co Lilly Sells 6,865 SharesEli Lilly And Co (LLY) Major Shareholder Eli & Co Lilly Sells 6,865 Shares
www.americanbankingnews.com - September 18 at 10:26 PM
Eli Lilly And Co (LLY) Rating Reiterated by BarclaysEli Lilly And Co (LLY) Rating Reiterated by Barclays
www.americanbankingnews.com - September 18 at 11:28 AM
Eli Lilly And Co (LLY) PT Set at $110.00 by Cantor FitzgeraldEli Lilly And Co (LLY) PT Set at $110.00 by Cantor Fitzgerald
www.americanbankingnews.com - September 18 at 8:46 AM
A Look at the Dividends Paid by Pharma Stocks in 2018A Look at the Dividends Paid by Pharma Stocks in 2018
finance.yahoo.com - September 18 at 8:39 AM
Eli Lilly And Co (LLY) Expected to Post Quarterly Sales of $6.07 BillionEli Lilly And Co (LLY) Expected to Post Quarterly Sales of $6.07 Billion
www.americanbankingnews.com - September 18 at 1:22 AM
Analysts Raise Ratings on Teva Stock on Ajovy’s FDA ApprovalAnalysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval
finance.yahoo.com - September 17 at 5:08 PM
Eli Lilly And Co (LLY) Expected to Announce Earnings of $1.35 Per ShareEli Lilly And Co (LLY) Expected to Announce Earnings of $1.35 Per Share
www.americanbankingnews.com - September 16 at 10:18 PM
Eli Lilly And Co (LLY) Given Average Recommendation of "Buy" by BrokeragesEli Lilly And Co (LLY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 15 at 4:36 PM
Gunderson Dettmer Wins “Finance & Transactional Impact Deal of the Year” for ARMO BioSciences/Eli Lilly M&A at 2018 LMG Life Sciences AwardsGunderson Dettmer Wins “Finance & Transactional Impact Deal of the Year” for ARMO BioSciences/Eli Lilly M&A at 2018 LMG Life Sciences Awards
globenewswire.com - September 15 at 8:35 AM
Insider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 10,059 Shares of StockInsider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 10,059 Shares of Stock
www.americanbankingnews.com - September 14 at 4:16 PM
New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research InstituteNew Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute
finance.yahoo.com - September 14 at 8:39 AM
Eli Lilly and Co (LLY) Presents at Morgan Stanley Healthcare Conference Broker Conference (Transcript)Eli Lilly and Co (LLY) Presents at Morgan Stanley Healthcare Conference Broker Conference (Transcript)
seekingalpha.com - September 13 at 4:46 PM
See what the IHS Markit Score report has to say about Eli Lilly And Co.See what the IHS Markit Score report has to say about Eli Lilly And Co.
finance.yahoo.com - September 13 at 4:46 PM
Why Eli Lilly (LLY) is a Great Dividend StockWhy Eli Lilly (LLY) is a Great Dividend Stock
finance.yahoo.com - September 13 at 4:46 PM
Eli Lilly and Co (LLY) Presents at Morgan Stanley Healthcare Conference Broker Conference Call - (Transcript)Eli Lilly and Co (LLY) Presents at Morgan Stanley Healthcare Conference Broker Conference Call - (Transcript)
seekingalpha.com - September 13 at 8:43 AM
Eli Lilly And Co (LLY) Major Shareholder Eli & Co Lilly Sells 4,500 SharesEli Lilly And Co (LLY) Major Shareholder Eli & Co Lilly Sells 4,500 Shares
www.americanbankingnews.com - September 12 at 7:48 PM
Mercks Antibacterial Drug Succeeds in Label Expansion StudyMerck's Antibacterial Drug Succeeds in Label Expansion Study
www.zacks.com - September 12 at 4:43 PM
Eli Lilly To Present At Morgan Stanley Conference; Webcast At 1:40 PM ETEli Lilly To Present At Morgan Stanley Conference; Webcast At 1:40 PM ET
www.nasdaq.com - September 12 at 4:43 PM
Eli Lilly & Co. (LLY) Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz and Tremfya in Patients with ...Eli Lilly & Co. (LLY) Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz and Tremfya in Patients with ...
www.streetinsider.com - September 12 at 4:43 PM
Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz® and Tremfya® in Patients with Moderate-to-Severe Plaque PsoriasisLilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz® and Tremfya® in Patients with Moderate-to-Severe Plaque Psoriasis
finance.yahoo.com - September 11 at 8:41 AM
Eli Lilly And Co (LLY) Major Shareholder Sells $19,216,800.00 in StockEli Lilly And Co (LLY) Major Shareholder Sells $19,216,800.00 in Stock
www.americanbankingnews.com - September 10 at 1:23 PM
AstraZeneca's Asthma Drug Gets Breakthrough Therapy StatusAstraZeneca's Asthma Drug Gets Breakthrough Therapy Status
finance.yahoo.com - September 7 at 4:56 PM
Barclays Reiterates Buy Rating for Eli Lilly And Co (LLY)Barclays Reiterates Buy Rating for Eli Lilly And Co (LLY)
www.americanbankingnews.com - September 7 at 9:24 AM
Eli Lillys Elanco sets IPO terms to raise up to $1.45 billion before optionsEli Lilly's Elanco sets IPO terms to raise up to $1.45 billion before options
www.marketwatch.com - September 6 at 8:45 AM
Elanco Announces Launch of IPO RoadshowElanco Announces Launch of IPO Roadshow
finance.yahoo.com - September 6 at 8:45 AM
Eli Lilly's Elanco sets IPO terms to raise up to $1.45 billion before optionsEli Lilly's Elanco sets IPO terms to raise up to $1.45 billion before options
finance.yahoo.com - September 6 at 8:45 AM
Lilly Announces Webcast to Discuss EASD PresentationsLilly Announces Webcast to Discuss EASD Presentations
finance.yahoo.com - September 6 at 8:45 AM
Lillys Elanco unit expects IPO to raise up to $1.45 billionLilly's Elanco unit expects IPO to raise up to $1.45 billion
finance.yahoo.com - September 6 at 8:45 AM
Eli Lillys PET imaging agent successful in late-stage studyEli Lilly's PET imaging agent successful in late-stage study
seekingalpha.com - September 5 at 4:55 PM
Donald A. Zakrowski Sells 600 Shares of Eli Lilly And Co (LLY) StockDonald A. Zakrowski Sells 600 Shares of Eli Lilly And Co (LLY) Stock
www.americanbankingnews.com - September 4 at 8:12 PM
Insurance tactic drags down US drug prices in 2nd quarter -analystInsurance tactic drags down US drug prices in 2nd quarter -analyst
www.nasdaq.com - September 4 at 4:58 PM
AstraZeneca Up This Year So Far on Favorable Pipeline UpdatesAstraZeneca Up This Year So Far on Favorable Pipeline Updates
finance.yahoo.com - September 4 at 4:58 PM
How Eli Lilly’s Elanco Performed in Q2 2018How Eli Lilly’s Elanco Performed in Q2 2018
finance.yahoo.com - September 4 at 4:58 PM
Insurance tactic drags down U.S. drug prices in 2nd quarter -analystInsurance tactic drags down U.S. drug prices in 2nd quarter -analyst
finance.yahoo.com - September 4 at 4:58 PM
Assessing Eli Lilly’s Human Pharmaceutical Segment in Q2 2018Assessing Eli Lilly’s Human Pharmaceutical Segment in Q2 2018
finance.yahoo.com - September 3 at 8:28 AM
$6.07 Billion in Sales Expected for Eli Lilly And Co (LLY) This Quarter$6.07 Billion in Sales Expected for Eli Lilly And Co (LLY) This Quarter
www.americanbankingnews.com - September 1 at 1:24 AM
Insider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 190,000 Shares of StockInsider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 190,000 Shares of Stock
www.americanbankingnews.com - August 31 at 10:39 AM
Anne White Promoted to President of Lilly OncologyAnne White Promoted to President of Lilly Oncology
finance.yahoo.com - August 30 at 5:05 PM
Opportunities in the Global Psoriasis Therapeutics Market to 2026 - Player Profiles for J&J, Novartis, Merck, Janssen, Eli Lilly and Co, Eisai, Celgene, BMS, and more ...Opportunities in the Global Psoriasis Therapeutics Market to 2026 - Player Profiles for J&J, Novartis, Merck, Janssen, Eli Lilly and Co, Eisai, Celgene, BMS, and more ...
www.businesswire.com - August 30 at 8:44 AM
Eli Lilly CEO: Why Consumers Are Key to Bringing Down Health Care CostsEli Lilly CEO: Why Consumers Are Key to Bringing Down Health Care Costs
fortune.com - August 27 at 5:01 PM
This page was last updated on 9/22/2018 by MarketBeat.com Staff

Featured Article: Closed-End Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel